Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders.

Ortega RM, Rodríguez-Rodríguez E, López-Sobaler AM.

Br J Nutr. 2012 Jun;107 Suppl 2:S261-70. doi: 10.1017/S000711451200164X. Review.

PMID:
22591900
2.

Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies.

Fusar-Poli P, Berger G.

J Clin Psychopharmacol. 2012 Apr;32(2):179-85. doi: 10.1097/JCP.0b013e318248b7bb. Review.

PMID:
22367656
3.

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

Narendran R, Lopresti BJ, Martinez D, Mason NS, Himes M, May MA, Daley DC, Price JC, Mathis CA, Frankle WG.

Am J Psychiatry. 2012 Jan;169(1):55-63. doi: 10.1176/appi.ajp.2011.11010126. Epub 2011 Oct 31.

4.

Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.

Sublette ME, Ellis SP, Geant AL, Mann JJ.

J Clin Psychiatry. 2011 Dec;72(12):1577-84. doi: 10.4088/JCP.10m06634. Epub 2011 Sep 6.

5.

Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.

Sarris J, Mischoulon D, Schweitzer I.

J Clin Psychiatry. 2012 Jan;73(1):81-6. doi: 10.4088/JCP.10r06710. Epub 2011 Aug 9.

PMID:
21903025
6.

The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.

Stough C, Downey L, Silber B, Lloyd J, Kure C, Wesnes K, Camfield D.

Neurobiol Aging. 2012 Apr;33(4):824.e1-3. doi: 10.1016/j.neurobiolaging.2011.03.019. Epub 2011 May 4.

PMID:
21531481
7.

Catecholamine influences on dorsolateral prefrontal cortical networks.

Arnsten AF.

Biol Psychiatry. 2011 Jun 15;69(12):e89-99. doi: 10.1016/j.biopsych.2011.01.027. Epub 2011 Apr 13. Review.

8.

Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC, Kumar D, Van Heertum R, Kleber HD, Nunes E.

Am J Psychiatry. 2011 Jun;168(6):634-41. doi: 10.1176/appi.ajp.2010.10050748. Epub 2011 Mar 15. Erratum in: Am J Psychiatry. 2011 May;168(5):553.

9.

Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood.

Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck SB.

J Nutr. 2010 Apr;140(4):848-53. doi: 10.3945/jn.109.119578. Epub 2010 Feb 24.

10.

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE.

Arch Gen Psychiatry. 2010 Feb;67(2):146-54. doi: 10.1001/archgenpsychiatry.2009.192.

PMID:
20124114
11.

A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.

Narendran R, Mason NS, Laymon CM, Lopresti BJ, Velasquez ND, May MA, Kendro S, Martinez D, Mathis CA, Frankle WG.

J Pharmacol Exp Ther. 2010 May;333(2):533-9. doi: 10.1124/jpet.109.163501. Epub 2010 Jan 26.

12.

Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review.

Turnbull T, Cullen-Drill M, Smaldone A.

Arch Psychiatr Nurs. 2008 Oct;22(5):305-11. doi: 10.1016/j.apnu.2008.02.011. Review.

PMID:
18809123
13.

Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial.

van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP.

Neurology. 2008 Aug 5;71(6):430-8. doi: 10.1212/01.wnl.0000324268.45138.86.

PMID:
18678826
14.

Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study.

Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, Abbott RD, Evans RW, Rodriguez BL, Okamura T, Sutton-Tyrrell K, Nakamura Y, Masaki K, Edmundowicz D, Kashiwagi A, Willcox BJ, Takamiya T, Mitsunami K, Seto TB, Murata K, White RL, Kuller LH; ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group..

J Am Coll Cardiol. 2008 Aug 5;52(6):417-24. doi: 10.1016/j.jacc.2008.03.047.

15.

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.

Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1538-44. doi: 10.1016/j.pnpbp.2008.05.015. Epub 2008 May 25.

PMID:
18573585
16.

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M.

Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9.

PMID:
17582225
17.

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE.

J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. Epub 2007 May 9. Review.

PMID:
17519979
18.

Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, Laruelle M.

Am J Psychiatry. 2007 Apr;164(4):622-9.

PMID:
17403976
19.

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.

Arch Neurol. 2006 Oct;63(10):1402-8.

PMID:
17030655
20.

Omega-3 fatty acids and monoamine neurotransmission.

Chalon S.

Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):259-69. Epub 2006 Sep 11. Review.

PMID:
16963244

Supplemental Content

Support Center